Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameh Saber

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. <i>Pharmaceuticals</i> 2023, <i>16</i>, 953Sameh Saber, Mohannad Mohammad S Alamri, Jaber Alfaifi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2025
A Systems Biology Perspective on Childhood ADHD: Neurochemical Dysregulation, Brain-Behavior Interactions, and Emerging TherapeuticsNorah Suliman Alsoqih, Elsayed A Elmorsy, Rasha Abu-Khudir, et al.
Tissue & Cell|March 7, 2026
The nano-biointerface as a structural regulator of cell behavior: Interactions of extracellular vesicles, synthetic nanocarriers, and nanofibers with cellsRabab S Hamad, Sameh Saber, Alshaimaa A Farrag, et al.
Frontiers in Pharmacology|January 31, 2022
AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular CarcinomaEslam E Abd El-Fattah, Sameh Saber, Mahmoud E Youssef, et al.
European Journal of Pharmacology|January 25, 2026
Reprogramming lysosomal-purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin-P2X7 blockade in diabetic ratsElsayed A Elmorsy, Manal Mohamed Hatem, Hamad Alsaykhan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2026
A Spatial-Mechanistic Design Map for Microenvironment-Responsive Nanomaterials in Solid TumorsRabab S Hamad, Sameh Saber, Ahmed Sameh, et al.
Chemico-Biological Interactions|August 29, 2025
Reprogramming the hepatic immune microenvironment with mirtazapine in early neoplastic transformation: Evidence from a diethylnitrosamine-induced rat modelElsayed A Elmorsy, Sameh Saber, Ahmad H Alhowail, et al.
International Immunopharmacology|September 2, 2025
MDL-800 protects against inflammatory and metabolic dysfunction: role of SIRT6 in the cross-regulation of NFκB, AMPK, and PPAR signaling in ratsRabab S Hamad, Waseem Ali Hasan, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosisDalia H El-Kashef, Mahmoud E Youssef, Mohamed Nasr, et al.
Frontiers in Pharmacology|April 1, 2025
E1231/NMN protects against experimental metabolic syndrome: the central role of SIRT1 in modulating AKT/Nrf2/NFκB signalingElsayed A Elmorsy, Hala A Elashry, Abdullah S Alkhamiss, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. <i>Pharmaceuticals</i> 2023, <i>16</i>, 953Sameh Saber, Mohannad Mohammad S Alamri, Jaber Alfaifi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2025
A Systems Biology Perspective on Childhood ADHD: Neurochemical Dysregulation, Brain-Behavior Interactions, and Emerging TherapeuticsNorah Suliman Alsoqih, Elsayed A Elmorsy, Rasha Abu-Khudir, et al.
Tissue & Cell|March 7, 2026
The nano-biointerface as a structural regulator of cell behavior: Interactions of extracellular vesicles, synthetic nanocarriers, and nanofibers with cellsRabab S Hamad, Sameh Saber, Alshaimaa A Farrag, et al.
Frontiers in Pharmacology|January 31, 2022
AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular CarcinomaEslam E Abd El-Fattah, Sameh Saber, Mahmoud E Youssef, et al.
European Journal of Pharmacology|January 25, 2026
Reprogramming lysosomal-purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin-P2X7 blockade in diabetic ratsElsayed A Elmorsy, Manal Mohamed Hatem, Hamad Alsaykhan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2026
A Spatial-Mechanistic Design Map for Microenvironment-Responsive Nanomaterials in Solid TumorsRabab S Hamad, Sameh Saber, Ahmed Sameh, et al.
Chemico-Biological Interactions|August 29, 2025
Reprogramming the hepatic immune microenvironment with mirtazapine in early neoplastic transformation: Evidence from a diethylnitrosamine-induced rat modelElsayed A Elmorsy, Sameh Saber, Ahmad H Alhowail, et al.
International Immunopharmacology|September 2, 2025
MDL-800 protects against inflammatory and metabolic dysfunction: role of SIRT6 in the cross-regulation of NFκB, AMPK, and PPAR signaling in ratsRabab S Hamad, Waseem Ali Hasan, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosisDalia H El-Kashef, Mahmoud E Youssef, Mohamed Nasr, et al.
Frontiers in Pharmacology|April 1, 2025
E1231/NMN protects against experimental metabolic syndrome: the central role of SIRT1 in modulating AKT/Nrf2/NFκB signalingElsayed A Elmorsy, Hala A Elashry, Abdullah S Alkhamiss, et al.
Pageof 14